logo-loader
viewOrgenesis

Orgenesis Inc outlines ways in which the group is aiming to combat the coronavirus

Orgenesis Inc (NASDAQ:ORGS) CEO Vered Caplan updates Proactive on ways in which the group is aiming to combat the coronavirus. Caplan spoke to Proactive about its BioShield Program, which is designed to use neutralizing human antibodies as a possible rapid defense and to potentially mitigate the spread of viruses such as the coronavirus that causes the COVID-19 disease.

Quick facts: Orgenesis

Price: 5.36 USD

NASDAQ:ORGS
Market: NASDAQ
Market Cap: $118.43 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Orgenesis named herein, including the promotion by the Company of Orgenesis in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bango reports record revenue growth in the first half of 2020

Bango PLC's (LON:BGO) Paul Larbey talks to Proactive's Katie Pilbeam `about their latest record revenue growth in the first half of this year. Larbey is confident Bango is positioned to continue delivering growth after reporting revenues of £4.77mln, up 50% year-on-year. He goes on to...

7 hours, 51 minutes ago

2 min read